Negative TdT Expression Predicts Adverse Treatment Outcome in T-Lymphoblastic Leukemia/Lymphoma in Adults

被引：0
|
作者：
Zhou, Y. [1 ]
Routbort, M. [1 ]
Young, K. H. [1 ]
Wang, S. [1 ]
Hoehn, D. [1 ]
Tang, G. [1 ]
Bueso-Ramos, C. [1 ]
Yin, C. C. [1 ]
Miranda, R. N. [1 ]
Medeiros, L. J. [1 ]
Lin, P. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1614
引用
收藏
页码：386A / 386A
页数：1
相关论文
共 50 条
  • [1] Negative TdT Expression Predicts Adverse Treatment Outcome in T-Lymphoblastic Leukemia/Lymphoma in Adults
    Zhou, Y.
    Routbort, M.
    Young, K. H.
    Wang, S.
    Hoelm, D.
    Tang, G.
    Bueso-Ramos, C.
    Yin, C. C.
    Miranda, R. N.
    Medeiros, L. J.
    Lin, P.
    LABORATORY INVESTIGATION, 2012, 92 : 386A - 386A
  • [2] High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults
    Baldus, Claudia D.
    Burmeister, Thomas
    Martus, Peter
    Schwartz, Stefan
    Goekbuget, Nicola
    Bloomfield, Clara D.
    Hoelzer, Dieter
    Thiel, Eckhard
    Hofmann, Wolf K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4714 - 4720
  • [3] T-Lymphoblastic Leukemia/Lymphoma
    You, M. James
    Medeiros, L. Jeffrey
    Hsi, Eric D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (03) : 411 - 422
  • [4] High expression of the transcription factor ERG predicts unfavorable outcome in acute T-lymphoblastic leukemia (T-ALL) in adults.
    Baldus, C. D.
    Burmeister, T.
    Martus, P.
    Schwartz, S.
    Goekbuget, N.
    Bloomfield, C. D.
    Hoelzer, D.
    Hofmann, W. K.
    Thiel, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 338S - 338S
  • [5] T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcome
    Fortune, Anne
    O'Leary, Hilary
    Gilmore, Ruth
    Chadwick, Nick
    Brennan, Lorraine
    Chonghaile, Mairead Ni
    Mccann, Shaun R.
    Browne, Paul V.
    Conneally, Eibhlin
    Vandenberghe, Elisabeth
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1035 - 1039
  • [6] Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial
    Hunault, Mathilde
    Truchan-Graczyk, Malgorzata
    Caillot, Denis
    Harousseau, Jean-Luc
    Bologna, Serge
    Himberlin, Chantal
    Guyotat, Denis
    Berthou, Christian
    Casassus, Philippe
    Baranger, Laurence
    Bene, Marie-Christine
    Ifrah, Norbert
    Gyan, Emmanuel
    HAEMATOLOGICA, 2007, 92 (12) : 1623 - 1630
  • [7] Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia
    Hoelzer, D
    Gökbuget, N
    Digel, W
    Faak, T
    Kneba, M
    Reutzel, R
    Romejko-Jarosinska, J
    Zwolinski, J
    Walewski, J
    BLOOD, 2002, 99 (12) : 4379 - 4385
  • [8] A case report of a patient with T-lymphoblastic leukemia / lymphoma
    Cholakova, M.
    Staikov, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 999 - 999
  • [9] sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma
    Liu, Juan
    Li, Mingyong
    Fu, Jun
    Dong, Min
    Fan, Xiaoming
    Zhong, Ling
    Xu, Gang
    Li, Yanxin
    Xi, Qian
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (11) : 1325 - 1331
  • [10] Absence of expression of CD34 and TdT is more common in precursor T-lymphoblastic leukemia than in precursor B-lymphoblastic leukemia
    Gupta, A.
    Lin, P.
    Gheorghe, G.
    Dunphy, C. H.
    Sun, T.
    Lovell, M. A.
    Dirks, N.
    Liang, X.
    MODERN PATHOLOGY, 2007, 20 : 242A - 242A
12345